Roydhouse Jessica K, Wilson Ira B, Gutman Roee, Wallace Robert B, Berman Tara, Keating Nancy L
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA.
J Patient Exp. 2021 Oct 27;8:23743735211049665. doi: 10.1177/23743735211049665. eCollection 2021.
The aim was to examine the association of patient-reported physician awareness of biological CAM use and patient perceptions of care experience and quality with a population-based study of patients with incident lung and colorectal cancer. This was a secondary data analysis using regression models. Outcomes of interest were patient reports of medical care experience and quality ratings. Among 716 patients who reported biological CAM use, 69% reported their physicians were aware of this. Patients who reported physician awareness of biological CAM use had higher adjusted scores for medical care experience ( + 5.4, 95%CI:2.3,8.6) and care quality ( + 3.6, 95%CI:-0.3, + 7.5). These associations suggest that physicians should be encouraged to inquire about biological CAM use.
目的是通过一项基于人群的肺癌和结直肠癌患者研究，探讨患者报告的医生对生物补充替代医学（CAM）使用的认知与患者对护理体验和质量的看法之间的关联。这是一项使用回归模型的二次数据分析。感兴趣的结果是患者对医疗护理体验和质量评分的报告。在报告使用生物CAM的716名患者中，69%报告其医生知晓此事。报告医生知晓生物CAM使用情况的患者在医疗护理体验（+5.4，95%置信区间：2.3，8.6）和护理质量（+3.6，95%置信区间：-0.3，+7.5）方面的调整得分更高。这些关联表明应鼓励医生询问患者生物CAM的使用情况。
